Cassava Sciences | PTIE - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Abbott USD 52.06B 69M 2026-03
Amgen USD 11.69B 2.5B 2026-06
Biogen USD 18.85B 196.3M 2026-06
Cara Therapeutics USD 14.5M 6.44M 2026-03
Cassava Sciences USD 68.14M 6.26M 2026-03
Eisai JPY 906.56B 7.57B 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Geron USD 218.61M 10.49M 2026-06
J&J USD 84.97B 3.78B 2026-06
Merck USD 41.93B 3.94B 2026-06
Novartis USD 41.95B 3.02B 2026-06
Novavax USD -190.71M 45.94M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06